Literature DB >> 15733634

Evidence for a long-term influence on morphine tolerance after previous morphine exposure: role of neuronal glucocorticoid receptors.

Grewo Lim1, Shuxing Wang, Qing Zeng, Backil Sung, Jianren Mao.   

Abstract

Opioid analgesic tolerance is a pharmacological phenomenon that overtime diminishes the opioid analgesic effect. However, it remains unknown as to whether a previous opioid exposure would have a long-term influence on opioid tolerance upon subsequent opioid administration. Here, we show that the onset and degree of antinociceptive tolerance to a subsequent cycle of morphine exposure were substantially exacerbated in rats made tolerant to and then recovered from previous morphine administration, indicating a long-term influence from a previous morphine exposure on the development of morphine tolerance. Mechanistically, morphine exposure induced a cyclic AMP and protein kinase A-dependent upregulation of neuronal glucocorticoid receptors (GR) within the spinal cord dorsal horn, which was maintained after discontinuation of morphine administration and significantly enhanced upon a second cycle of morphine exposure. Prevention of the GR upregulation with GR antisense oligonucleotides as well as inhibition of GR activation with the GR antagonist RU38486 effectively prevented the exacerbated morphine tolerance after subsequent cycles of morphine exposure. The results indicate that a previous morphine exposure could induce lasting cellular changes mediated through neuronal GR and influence morphine analgesia upon a subsequent exposure. These findings may have significant implications in clinical opioid therapy and substance abuse.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15733634     DOI: 10.1016/j.pain.2004.11.019

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  8 in total

1.  Nociceptive behavior following hindpaw burn injury in young rats: response to systemic morphine.

Authors:  Shuxing Wang; Lin Zhang; Yuxin Ma; Lucy Chen; Yinghong Tian; Jianren Mao; Jeevendra J A Martyn
Journal:  Pain Med       Date:  2010-12-10       Impact factor: 3.750

Review 2.  The potential contribution of stress systems to the transition to chronic whiplash-associated disorders.

Authors:  Samuel A McLean
Journal:  Spine (Phila Pa 1976)       Date:  2011-12-01       Impact factor: 3.468

3.  Biomarkers of morphine tolerance and dependence are prevented by morphine-induced endocytosis of a mutant mu-opioid receptor.

Authors:  Li He; Joseph A Kim; Jennifer L Whistler
Journal:  FASEB J       Date:  2009-08-13       Impact factor: 5.191

Review 4.  Chronic daily headache: transformational migraine, chronic migraine, and related disorders.

Authors:  Joel R Saper
Journal:  Curr Neurol Neurosci Rep       Date:  2008-03       Impact factor: 5.081

5.  Higher opioid doses predict poorer functional outcome in patients with chronic disabling occupational musculoskeletal disorders.

Authors:  Cindy L Kidner; Tom G Mayer; Robert J Gatchel
Journal:  J Bone Joint Surg Am       Date:  2009-04       Impact factor: 5.284

6.  White matter abnormalities correlating with memory and depression in heroin users under methadone maintenance treatment.

Authors:  Wei-Che Lin; Kun-Hsien Chou; Chien-Chih Chen; Chu-Chung Huang; Hsiu-Ling Chen; Cheng-Hsien Lu; Shau-Hsuan Li; Ya-Ling Wang; Yu-Fan Cheng; Ching-Po Lin
Journal:  PLoS One       Date:  2012-04-09       Impact factor: 3.240

7.  Endoplasmic Reticulum Stress in Spinal Cord Contributes to the Development of Morphine Tolerance.

Authors:  Daiqiang Liu; Yaqun Zhou; Yawen Peng; Peng Su; Zheng Li; Qiaoqiao Xu; Ye Tu; Xuebi Tian; Hui Yang; Zhen Wu; Wei Mei; Feng Gao
Journal:  Front Mol Neurosci       Date:  2018-03-06       Impact factor: 5.639

8.  Astroglial Knockout of Glucocorticoid Receptor Attenuates Morphine Withdrawal Symptoms, but Not Antinociception and Tolerance in Mice.

Authors:  Magdalena Tertil; Urszula Skupio; Lucja Kudla; Lucja Wiktorowska; Ryszard Przewlocki
Journal:  Cell Mol Neurobiol       Date:  2021-04-05       Impact factor: 4.231

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.